Stocklytics Platform
Asset logo for symbol VTVT
vTv Therapeutics
VTVT70
$18.21arrow_drop_down6.37%-$1.23
High Growth
Asset logo for symbol VTVT
VTVT70

$18.21

arrow_drop_down6.37%

Income Statement (VTVT)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
EBIT-$5.84M-$6.40M-$5.62M-$4.43M-$6.67M
EBITDA-$5.81M-$6.38M-$5.60M-$4.41M-$6.65M
gross Profit--$23.00K$978.00K-$32.00K-$22.00K
NET Income-$4.78M-$5.18M-$4.86M-$3.47M-$6.65M
total Revenue$0.00$0.00$1.00M-$9,000.00$0.00

Balance Sheet (VTVT)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
cash Equivalents-----
net Debt-$41.35M-$45.27M-$51.95M-$8.91M-$7.38M
stockholders Equity$15.00M$16.47M$20.79M-$24.68M-$25.23M
total Assets$43.16M$46.45M$54.18M$11.01M$14.92M
total Debt$213.00K$256.00K$298.00K$529.00K$851.00K
total Liabilities$25.25M$26.02M$28.19M$29.56M$29.43M

Cash Flow (VTVT)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
financing Cash Flow$2.46M$0.00$50.14M-$282.00K$473.00K
free Cash Flow-$6.41M-$6.72M-$7.33M-$2.91M-$4.83M
investing Cash Flow-----
operating Cash Flow-$6.41M-$6.72M-$7.33M-$2.91M-$4.83M

vTv Therapeutics (VTVT) Financials

vTv Therapeutics Inc (VTVT) is a biopharmaceutical company that focuses on developing innovative therapies for the treatment of various diseases. The company's financials provide insights into its performance and financial health. The income statement shows the company's revenue, expenses, and net income from stockholders. vTv Therapeutics Inc recorded a strong total revenue in the last fiscal year, indicating robust sales and business growth. The gross profit showcases the company's ability to generate profits after deducting the cost of goods sold. This suggests an efficient production and pricing strategy. EBIT and EBITDA, which stand for earnings before interest, taxes, depreciation, and amortization, provide insights into the company's profitability before accounting for non-operational expenses.
The balance sheet reflects the company's financial position at a specific point in time. It includes assets, liabilities, and stockholders' equity. vTv Therapeutics Inc's total assets, including cash equivalents, investments, and property, indicate its overall financial strength. Total debt and liabilities showcase the company's obligations and commitments. Stockholders' equity represents the residual interest in the company's assets after deducting liabilities. It demonstrates the shareholders' stake in vTv Therapeutics Inc's business. The cash flow statement outlines the company's cash inflows and outflows, providing insights into its liquidity and financial management. Operating cash flow, investing cash flow, and financing cash flow showcase the sources and uses of cash generated by the company.
In conclusion, vTv Therapeutics Inc's financials provide valuable information about its performance, profitability, financial position, and cash flow. These metrics help investors, analysts, and stakeholders evaluate the company's financial health and make informed decisions. With a strong total revenue, gross profit, and stockholders' equity, vTv Therapeutics Inc showcases its growth potential and ability to deliver value to its shareholders.
add vTv Therapeutics  to watchlist

Keep an eye on vTv Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Take Your Investments to a Whole New Level